HIIT trimmed 24-hour glucose more than steady cardio

Type 2 diabetes is not just a matter of an average glucose level: it involves chronic hyperglycaemia alongside marked swings within a single day. Conventional markers capture the average but miss much of that texture, whereas continuous glucose monitoring describes overall exposure, what happens after meals, and how variable the readings are. High-intensity interval training has looked promising for glycaemic control because it is time-efficient and taxing, but its effects specifically on monitor-derived measures had never been pulled together. That gap is what this review set out to close.

The authors searched PubMed, Embase, Web of Science, the Cochrane Library and EBSCOhost from inception to 26 January 2026. They included interventional studies that compared HIIT either with a non-exercise control group or with another form of exercise, and that reported outcomes derived from continuous glucose monitoring. Where the data allowed, pooled estimates were calculated from change-from-baseline values using fixed- or random-effects models. Risk of bias was assessed with RoB 2, the crossover version of RoB 2, or ROBINS-I, and the certainty of the evidence was graded using GRADE. Twelve studies involving 177 participants met the criteria.

Against non-exercise control, HIIT reduced 24-hour mean glucose, postprandial glucose and the time spent in hyperglycaemia. Its effect on the mean amplitude of glycemic excursions, a measure of glucose variability, remained uncertain. Compared with moderate-intensity continuous training, HIIT produced further reductions in 24-hour mean glucose and in hyperglycaemic time, but there was no significant between-group difference for the variability measure. Overall certainty of the evidence ranged from very low to low, so the direction of effect is more secure than its size.

The result is consistent with earlier work suggesting HIIT helps glycaemic control in type 2 diabetes, and extends that literature to the richer set of measures a continuous monitor produces. It also complicates a common assumption, since the training that lowered average and post-meal glucose did not clearly flatten the within-day swings. With 12 studies and 177 participants between them, the evidence base is thin, and the comparison against moderate continuous training rests on fewer trials still. Longer, larger and better-controlled studies are needed before the apparent edge over steady-state training can be treated as settled.

For someone with type 2 diabetes who already exercises, this is a reason to think interval-style work may do at least as much for day-to-day glucose exposure as steady moderate sessions, and possibly a little more. The clearest signals were in average glucose across the day, glucose after meals, and time spent above range, rather than in how much glucose bounced around. It does not tell you how intense, how often or how long, because the pooled trials varied and the certainty was low. Anyone managing diabetes with medication has individual considerations that a pooled average cannot address.